{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:10Z","timestamp":1772120050814,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12149-025-02067-y","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:43:44Z","timestamp":1751291024000},"page":"1074-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of pre-treatment metabolic tumor volume on [S\u2011methyl\u201111C]\u2011L\u2011methionine PET\/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy"],"prefix":"10.1007","volume":"39","author":[{"given":"Kentaro","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi B.","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitsuro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-4737","authenticated-orcid":false,"given":"Tatsuya","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2067_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2067_CR2","first-page":"7082","volume":"24","author":"S Navada","year":"2006","unstructured":"Navada S, Lai P, Schwartz AG, Kalemkerian GP. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. J Clin Orthod. 2006;24:7082\u20137082.","journal-title":"J Clin Orthod"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol. 2021;7:1824\u201332.","journal-title":"JAMA Oncol"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S1470-2045(14)70412-7","volume":"16","author":"T Kamada","year":"2015","unstructured":"Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 2015;16:e93-100.","journal-title":"Lancet Oncol"},{"key":"2067_CR5","unstructured":"Particle Therapy Co-Operative Group. Particle therapy facilities under construction (update May 2025) [Internet]. Particle Therapy Co-Operative Group. 2025. Available from: https:\/\/www.ptcog.site\/index.php\/facilities-under-construction. Accessed on 29 May 2025."},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.suronc.2013.04.001","volume":"22","author":"J Li","year":"2013","unstructured":"Li J, Xu W, Kong F, Sun X, Zuo X. Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients. Surg Oncol. 2013;22:151\u20135.","journal-title":"Surg Oncol"},{"key":"2067_CR7","first-page":"615","volume":"25","author":"P Obara","year":"2013","unstructured":"Obara P, Pu Y. Prognostic value of metabolic tumor burden in lung cancer. Chin J Cancer Res. 2013;25:615\u201322.","journal-title":"Chin J Cancer Res"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.acra.2012.07.002","volume":"20","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, et al. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Acad Radiol. 2013;20:32\u201340.","journal-title":"Acad Radiol"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00259-017-3659-7","volume":"44","author":"JH Finkle","year":"2017","unstructured":"Finkle JH, Jo SY, Ferguson MK, Liu H-Y, Zhang C, Zhu X, et al. Risk-stratifying capacity of PET\/CT metabolic tumor volume in stage IIIA non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2017;44:1275\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11548-012-0749-7","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wroblewski K, Appelbaum D, Pu Y. Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer. Int J Comput Assist Radiol Surg. 2013;8:181\u201391.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2214\/AJR.16.16532","volume":"208","author":"S Sheikhbahaei","year":"2017","unstructured":"Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, et al. The value of FDG PET\/CT in treatment response assessment, follow-up, and surveillance of lung cancer. AJR Am J Roentgenol. 2017;208:420\u201333.","journal-title":"AJR Am J Roentgenol"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1053\/j.semnuclmed.2022.05.002","volume":"52","author":"MMK Krarup","year":"2022","unstructured":"Krarup MMK, Fischer BM, Christensen TN. New PET tracers: current knowledge and perspectives in lung cancer. Semin Nucl Med. 2022;52:781\u201396.","journal-title":"Semin Nucl Med"},{"key":"2067_CR13","first-page":"37","volume":"26","author":"K Kubota","year":"1985","unstructured":"Kubota K, Matsuzawa T, Ito M, Ito K, Fujiwara T, Abe Y, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med. 1985;26:37\u201342.","journal-title":"J Nucl Med"},{"key":"2067_CR14","first-page":"425","volume":"15","author":"K Kanegae","year":"2007","unstructured":"Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med [Internet]. 2007;15:425.","journal-title":"Ann Nucl Med [Internet]"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12149-007-0142-8","volume":"22","author":"HJ Hsieh","year":"2008","unstructured":"Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules\/masses when compared with 18F-FDG-PET. Ann Nucl Med. 2008;22:533\u20138.","journal-title":"Ann Nucl Med"},{"key":"2067_CR16","first-page":"CD009519","volume":"2016","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Figuls RIM. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;2016:CD009519.","journal-title":"Cochrane Database Syst Rev"},{"key":"2067_CR17","first-page":"283","volume":"41","author":"T Yasukawa","year":"2000","unstructured":"Yasukawa T, Yoshikawa K, Aoyagi H, Yamamoto N, Tamura K, Suzuki K, et al. Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med. 2000;41:283\u201390.","journal-title":"J Nucl Med"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/BF02985960","volume":"18","author":"T Ishimori","year":"2004","unstructured":"Ishimori T, Saga T, Nagata Y, Nakamoto Y, Higashi T, Mamede M, et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann Nucl Med. 2004;18:669\u201374.","journal-title":"Ann Nucl Med"},{"key":"2067_CR19","first-page":"1886","volume":"34","author":"H Miyazawa","year":"1993","unstructured":"Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J Nucl Med. 1993;34:1886\u201391.","journal-title":"J Nucl Med"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","volume":"70","author":"HN Christensen","year":"1990","unstructured":"Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev. 1990;70:43\u201377.","journal-title":"Physiol Rev"},{"key":"2067_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.564809","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xu Y, Li D, Fu L, Zhang X, Bao Y, et al. Review of the correlation of LAT1 with diseases: mechanism and treatment. Front Chem. 2020;8: 564809.","journal-title":"Front Chem"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.bjc.6604235","volume":"98","author":"K Kaira","year":"2008","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer. 2008;98:742\u20138.","journal-title":"Br J Cancer"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1349-7006.2008.01029.x","volume":"100","author":"K Kaira","year":"2009","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci. 2009;100:248\u201354.","journal-title":"Cancer Sci"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lungcan.2008.12.015","volume":"66","author":"K Kaira","year":"2009","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer. 2009;66:120\u20136.","journal-title":"Lung Cancer"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2559.2009.03300.x","volume":"54","author":"H Imai","year":"2009","unstructured":"Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, et al. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology. 2009;54:804\u201313.","journal-title":"Histopathology"},{"key":"2067_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233629","volume":"15","author":"J-J Lu","year":"2020","unstructured":"Lu J-J, Li P, Yang Y, Wang L, Zhang Y, Zhu J-Y, et al. Prognostic value of LAT-1 status in solid cancer: a systematic review and meta-analysis. PLoS ONE. 2020;15: e0233629.","journal-title":"PLoS ONE"},{"key":"2067_CR27","first-page":"1126","volume":"7","author":"T Yazawa","year":"2015","unstructured":"Yazawa T, Shimizu K, Kaira K, Nagashima T, Ohtaki Y, Atsumi J, et al. Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma. Am J Transl Res. 2015;7:1126\u201339.","journal-title":"Am J Transl Res"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jtho.2016.12.012","volume":"12","author":"N Yamamoto","year":"2017","unstructured":"Yamamoto N, Miyamoto T, Nakajima M, Karube M, Hayashi K, Tsuji H, et al. A Dose escalation clinical trial of single-fraction carbon ion radiotherapy for peripheral stage I non-small cell lung cancer. J Thorac Oncol. 2017;12:673\u201380.","journal-title":"J Thorac Oncol"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00259-014-2903-7","volume":"42","author":"HJ Im","year":"2015","unstructured":"Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ, et al. Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging [Internet]. 2015;42:241.","journal-title":"Eur J Nucl Med Mol Imaging [Internet]"},{"key":"2067_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/MNM.0b013e32836491a9","volume":"34","author":"CC Vu","year":"2013","unstructured":"Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH. Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET\/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Nucl Med Commun. 2013;34:959\u201363.","journal-title":"Nucl Med Commun"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1148\/radiol.13130652","volume":"270","author":"Y Satoh","year":"2014","unstructured":"Satoh Y, Onishi H, Nambu A, Araki T. Volume-based parameters measured by using FDG PET\/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology. 2014;270:275\u201381.","journal-title":"Radiology"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy P, Gyimesi G, Kanai Y, Hediger MA. Amino acid transporters revisited: new views in health and disease. Trends Biochem Sci. 2018;43:752\u201389.","journal-title":"Trends Biochem Sci"},{"key":"2067_CR33","first-page":"1211","volume":"32","author":"S Leskinen-Kallio","year":"1991","unstructured":"Leskinen-Kallio S, Ruotsalainen U, N\u00e5gren K, Ter\u00e4s M, Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin\u2019s lymphoma: a PET study. J Nucl Med. 1991;32:1211\u20138.","journal-title":"J Nucl Med"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12880-018-0292-2","volume":"18","author":"S Kumasaka","year":"2018","unstructured":"Kumasaka S, Nakajima T, Arisaka Y, Tokue A, Achmad A, Fukushima Y, et al. Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET\/CT in non-small cell lung Cancer. BMC Med Imaging. 2018;18:46.","journal-title":"BMC Med Imaging"},{"key":"2067_CR35","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2967\/jnumed.109.066837","volume":"50","author":"K Kaira","year":"2009","unstructured":"Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, et al. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer. J Nucl Med. 2009;50:1770\u20136.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02067-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T12:59:51Z","timestamp":1758373191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02067-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6310988\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}